[Clinical practice guidelines for retinitis pigmentosa]
Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association1, Zhenglin Yang, Jiyun Yang
1Medical College of University of Electronic Science and Technology, Affiliated Hospital of University of Electronic Science and Technology, Key Laboratory of Human Disease Gene Research, Sichuan Provincial People's Hospital, Chengdu 610072, China. zliny@yahoo.com.
Summary
Retinitis pigmentosa (RP) is a group of inherited retinal diseases affecting rod and cone cells, leading to progressive vision loss. This guideline standardizes RP diagnosis and treatment based on genetics and clinical findings.
Area of Science:
- Ophthalmology
- Genetics
- Medical Research
Background:
- Retinitis pigmentosa (RP) encompasses hereditary retinal disorders primarily impacting rod cells, with potential secondary cone cell dysfunction.
- Disease progression leads to gradual visual impairment, potentially resulting in complete blindness.
- Fundus examination often reveals morphological changes, including characteristic pigment abnormalities indicative of retinal degeneration.
Purpose of the Study:
- To establish standardized clinical diagnostic criteria for retinitis pigmentosa.
- To outline current treatment strategies for retinitis pigmentosa.
- To provide a comprehensive overview of RP etiology, pathogenesis, and genetic underpinnings.
Main Methods:
- Review of genetic heterogeneity and phenotypic diversity in RP.
- Analysis of over 90 identified pathogenic genes associated with RP.
- Consolidation of clinical consultation data for diagnostic and therapeutic standardization.
Main Results:
- RP presents significant genetic heterogeneity and diverse clinical phenotypes.
- Numerous pathogenic genes (over 90) have been identified, contributing to RP's complexity.
- Standardization of diagnosis and treatment is crucial for effective RP management.
Conclusions:
- Standardized guidelines are essential for consistent clinical diagnosis and treatment of retinitis pigmentosa.
- Understanding the genetic basis and pathogenesis of RP is key to developing targeted therapies.
- This guideline aims to improve patient outcomes through harmonized clinical approaches.
